166 related articles for article (PubMed ID: 36068674)
1. Combination of autologous platelet rich plasma and hydroquinone 4% is more effective than hydroquinone alone in treatment of melasma: A split-face comparative study.
Tekam PS; Belgaumkar VA
Dermatol Ther; 2022 Nov; 35(11):e15761. PubMed ID: 36068674
[TBL] [Abstract][Full Text] [Related]
2. Role of Platelet-Rich Plasma Therapy as an Adjuvant in Treatment of Melasma.
Bikash C; Sarkar R; Relhan V; Singh S
Dermatol Surg; 2022 Apr; 48(4):429-434. PubMed ID: 35143442
[TBL] [Abstract][Full Text] [Related]
3. Study of autologous platelet-rich-plasma versus its combination with intense pulsed light in treatment of melasma.
Adel S; Serri A; Abd El-Raheem T
Dermatol Ther; 2021 Jul; 34(4):e15008. PubMed ID: 34041826
[TBL] [Abstract][Full Text] [Related]
4. Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study.
Abd Elraouf IG; Obaid ZM; Fouda I
Arch Dermatol Res; 2023 Aug; 315(6):1763-1770. PubMed ID: 36856856
[TBL] [Abstract][Full Text] [Related]
5. Platelet-rich plasma is a useful therapeutic option in melasma.
Hofny ERM; Abdel-Motaleb AA; Ghazally A; Ahmed AM; Hussein MRA
J Dermatolog Treat; 2019 Jun; 30(4):396-401. PubMed ID: 30220226
[No Abstract] [Full Text] [Related]
6. Microneedling with glutathione versus microneedling alone in treatment of facial melasma: Split-face comparative study.
Mohamed M; Beshay YMA; Assaf HM
J Cosmet Dermatol; 2023 Dec; 22(12):3379-3386. PubMed ID: 37313658
[TBL] [Abstract][Full Text] [Related]
7. A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.
Patil NK; Bubna AK
Dermatol Ther; 2022 Jul; 35(7):e15534. PubMed ID: 35460158
[TBL] [Abstract][Full Text] [Related]
8. A Randomized, Double-Blind, Split-Face Study of Topical Silymarin vs 2% Hydroquinone Cream in Melasmas.
Wattanakrai P; Nimmannitya K
J Drugs Dermatol; 2022 Dec; 21(12):1304-1310. PubMed ID: 36468967
[TBL] [Abstract][Full Text] [Related]
9. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
Adalatkhah H; Sadeghi-Bazargani H
Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
[TBL] [Abstract][Full Text] [Related]
10. Split-face comparison of hydroquinone 4% plus nitrogen plasma vs. hydroquinone 4% alone in the treatment of melasma.
Yousefi M; Hadian K; Babossalam S; Diab R; Akhlaghi M; Aghighi M; Abdollahimajd F; Shokri B
Lasers Med Sci; 2023 Apr; 38(1):113. PubMed ID: 37103690
[TBL] [Abstract][Full Text] [Related]
11. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
Basit A; Rahman A; Uddin R
J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of topical 5% methimazole vs 4% hydroquinone in the treatment of melasma: A randomized controlled trial.
Gheisari M; Dadkhahfar S; Olamaei E; Moghimi HR; Niknejad N; Najar Nobari N
J Cosmet Dermatol; 2020 Jan; 19(1):167-172. PubMed ID: 31102345
[TBL] [Abstract][Full Text] [Related]
13. Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma.
Arrowitz C; Schoelermann AM; Mann T; Jiang LI; Weber T; Kolbe L
J Invest Dermatol; 2019 Aug; 139(8):1691-1698.e6. PubMed ID: 30825454
[TBL] [Abstract][Full Text] [Related]
14. Platelet-rich plasma treatment for melasma: A pilot study.
Sirithanabadeekul P; Dannarongchai A; Suwanchinda A
J Cosmet Dermatol; 2020 Jun; 19(6):1321-1327. PubMed ID: 31568636
[TBL] [Abstract][Full Text] [Related]
15. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
[TBL] [Abstract][Full Text] [Related]
16. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
Grimes PE
Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
[TBL] [Abstract][Full Text] [Related]
17. Comparative study between topical tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma.
Gamea MM; Kamal DA; Donia AA; Hegab DS
J Dermatolog Treat; 2022 Mar; 33(2):798-804. PubMed ID: 32567984
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of tranexamic acid 5% cream vs hydroquinone 4% cream in treating melasma: A split-face comparative clinical, histopathological, and antera 3D camera study.
El-Husseiny R; Rakha N; Sallam M
Dermatol Ther; 2020 Nov; 33(6):e14240. PubMed ID: 32856757
[TBL] [Abstract][Full Text] [Related]
19. Clinical, dermoscopic, and histopathologic evaluation of vitamin C versus PRP, with microneedling in the treatment of mixed melasma: A split-face, comparative study.
Abdel-Rahman AT; Abdel-Hakeem FG; Ragaie MH
Dermatol Ther; 2022 Feb; 35(2):e15239. PubMed ID: 34851010
[TBL] [Abstract][Full Text] [Related]
20. Comparison of therapeutic effects of conventional and liposomal form of 4% topical hydroquinone in patients with melasma.
Taghavi F; Banihashemi M; Zabolinejad N; Salehi M; Jaafari MR; Marhamati H; Golnouri F; Dorri M
J Cosmet Dermatol; 2019 Jun; 18(3):870-873. PubMed ID: 30105847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
